Results 201 to 210 of about 46,701 (237)
Some of the next articles are maybe not open access.
JAMA: The Journal of the American Medical Association, 1972
To the Editor.— Rifampin is an effective antituberculous drug recently approved by the Food and Drug Administration for general use. Users are warned that Rifampin has been shown to produce liver dysfunction. There have been fatalities associated with jaundice in patients with liver disease or receiving rifampin concomitantly with other hepatotoxic ...
openaire +2 more sources
To the Editor.— Rifampin is an effective antituberculous drug recently approved by the Food and Drug Administration for general use. Users are warned that Rifampin has been shown to produce liver dysfunction. There have been fatalities associated with jaundice in patients with liver disease or receiving rifampin concomitantly with other hepatotoxic ...
openaire +2 more sources
Archives of Internal Medicine, 1987
To the Editor. —In their recent article, Baciewicz et al 1 presented an excellent update on rifampin drug interactions. There are, however, two therapeutic agents (ethionamide and protionamide) not mentioned that may have serious to potentially fatal consequences when used with rifampin.
openaire +2 more sources
To the Editor. —In their recent article, Baciewicz et al 1 presented an excellent update on rifampin drug interactions. There are, however, two therapeutic agents (ethionamide and protionamide) not mentioned that may have serious to potentially fatal consequences when used with rifampin.
openaire +2 more sources
TO RIFAMPIN OR NOT TO RIFAMPIN?!
Journal of the American College of Cardiology, 2022Faysal Alhasan +2 more
openaire +1 more source